DAEWOONG PHARMA Logo

DAEWOONG PHARMA

A global R&D partner for drug development, manufacturing, and commercialization services.

069620 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 화성시 향남읍 제약공단4길 35-14, 화성시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Daewoong Pharmaceutical is a research and development-oriented pharmaceutical company established in 1945. The company manufactures and sells a range of healthcare products, including prescription drugs, over-the-counter medicines, and active pharmaceutical ingredients (APIs). A core component of its strategy is an "Open Collaboration" model, through which it partners with academic and industry collaborators globally to develop innovative, first-in-class drugs. Daewoong provides comprehensive support to its partners, including R&D investment, access to GMP-certified manufacturing facilities for biologics like stem cells, clinical trial support, and formulation services, from initial idea validation through to commercialization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Regulatory News Service
투자판단관련주요경영사항
Korean 14.2 KB
2025-09-05 00:00
Regulatory News Service
투자판단관련주요경영사항
Korean 8.3 KB
2025-08-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.5 KB
2025-08-18 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 37.1 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 4.1 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 6.5 MB
2025-07-31 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.2 KB
2025-07-30 00:00
Regulatory News Service
투자판단관련주요경영사항
Korean 8.8 KB
2025-07-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 101.6 KB
2025-06-30 00:00
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
Korean 9.8 KB
2025-06-02 00:00
Governance Information
기업지배구조보고서공시
Korean 743.9 KB
2025-05-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-05-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 169.8 KB
2025-05-16 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 40.5 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.3 MB

Automate Your Workflow. Get a real-time feed of all DAEWOONG PHARMA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DAEWOONG PHARMA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.